Subgroups and Heterogeneity in Cost-Effectiveness Analysis

被引：0
|
作者：
Mark Sculpher
机构：
[1] University of York,Centre for Health Economics and NICE Decision Support Unit
来源：
PharmacoEconomics | 2008年 / 26卷
关键词：
Cost Effectiveness; Alteplase; Health Gain; Relative Treatment Effect; Public Preference;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The National Institute for Health and Clinical Excellence (NICE) is required to consider cost effectiveness when issuing guidance about the use of health technologies within the UK NHS. Cost effectiveness is a means of supporting a system objective of maximizing population health gain from the available budget.
引用
收藏
页码：799 / 806
页数：7
相关论文
共 50 条
  • [1] Subgroups and heterogeneity in cost-effectiveness analysis
    Sculpher, Mark
    [J]. PHARMACOECONOMICS, 2008, 26 (09) : 799 - 806
  • [2] Using causal forests to assess heterogeneity in cost-effectiveness analysis
    Bonander, Carl
    Svensson, Mikael
    [J]. HEALTH ECONOMICS, 2021, 30 (08) : 1818 - 1832
  • [3] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [4] Cost-effectiveness analysis
    Stein, Sherman C.
    Malhotra, Neil R.
    Burnett, Mark G.
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2014, 20 (04) : 474 - 474
  • [5] COST-EFFECTIVENESS ANALYSIS
    GANIATS, TG
    [J]. PRIMARY CARE, 1995, 22 (02): : 307 - 318
  • [6] Cost-effectiveness analysis
    Yates, BT
    [J]. EVALUATION AND PROGRAM PLANNING, 2002, 25 (02) : 201 - 202
  • [7] COST-EFFECTIVENESS ANALYSIS
    BALAKRISHNA, S
    [J]. JOURNAL OF RURAL DEVELOPMENT, 1992, 11 (05) : 701 - 703
  • [8] THE VALUE OF HETEROGENEITY FOR COST-EFFECTIVENESS SUBGROUP ANALYSIS: THEORETICAL FRAMEWORK AND APPLICATION
    Espinoza, M.
    Manca, A.
    Claxton, K.
    Sculpher, M. J.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A241 - A241
  • [9] The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis: Conceptual Framework and Application
    Espinoza, Manuel A.
    Manca, Andrea
    Claxton, Karl
    Sculpher, Mark J.
    [J]. MEDICAL DECISION MAKING, 2014, 34 (08) : 951 - 964
  • [10] (HOW) SHOULD COST-EFFECTIVENESS ANALYSIS ACCOMMODATE HETEROGENEITY IN PATIENT PREFERENCES?
    Hawkins, N.
    Szabo, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S469 - S469
12345